Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression.

Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE.

J Immunol. 2011 Feb 15;186(4):2613-22. doi: 10.4049/jimmunol.1003162. Epub 2011 Jan 17.

2.

Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.

Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE.

J Biol Chem. 2004 Apr 2;279(14):13677-88. Epub 2004 Jan 20.

3.

Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.

Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL.

J Immunol. 2013 Mar 1;190(5):2252-62. doi: 10.4049/jimmunol.1201505. Epub 2013 Jan 28.

4.

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.

Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY.

J Immunol. 2003 Sep 15;171(6):3262-9.

5.

EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner.

Johnston A, Gudjonsson JE, Aphale A, Guzman AM, Stoll SW, Elder JT.

J Invest Dermatol. 2011 Feb;131(2):329-37. doi: 10.1038/jid.2010.313. Epub 2010 Oct 21.

6.

Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells.

Chustz RT, Nagarkar DR, Poposki JA, Favoreto S Jr, Avila PC, Schleimer RP, Kato A.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):145-53. doi: 10.1165/rcmb.2010-0075OC. Epub 2010 Sep 24.

7.

IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8.

Costelloe C, Watson M, Murphy A, McQuillan K, Loscher C, Armstrong ME, Garlanda C, Mantovani A, O'Neill LA, Mills KH, Lynch MA.

J Neurochem. 2008 Jun;105(5):1960-9. doi: 10.1111/j.1471-4159.2008.05304.x. Epub 2008 Feb 18.

8.

IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.

Foster AM, Baliwag J, Chen CS, Guzman AM, Stoll SW, Gudjonsson JE, Ward NL, Johnston A.

J Immunol. 2014 Jun 15;192(12):6053-61. doi: 10.4049/jimmunol.1301481. Epub 2014 May 14.

9.

IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.

Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S.

Inflamm Bowel Dis. 2014 Nov;20(11):1891-901. doi: 10.1097/MIB.0000000000000198.

PMID:
25299544
10.

Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY.

N Engl J Med. 2002 Oct 10;347(15):1151-60.

11.

The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.

Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, Kasman I, Winer J, Modrusan Z, Danilenko DM, Ouyang W.

J Immunol. 2007 Feb 15;178(4):2229-40. Erratum in: J Immunol. 2007 Jun 1;178(11):7487.

12.
13.

Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin.

Hau CS, Kanda N, Noda S, Tatsuta A, Kamata M, Shibata S, Asano Y, Sato S, Watanabe S, Tada Y.

Am J Pathol. 2013 May;182(5):1705-17. doi: 10.1016/j.ajpath.2013.01.044. Epub 2013 Mar 15.

PMID:
23499548
14.

Psoriasis and other Th17-mediated skin diseases.

Tokura Y, Mori T, Hino R.

J UOEH. 2010 Dec 1;32(4):317-28. Review.

PMID:
21226422
15.

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.

Blumberg H, Dinh H, Dean C Jr, Trueblood ES, Bailey K, Shows D, Bhagavathula N, Aslam MN, Varani J, Towne JE, Sims JE.

J Immunol. 2010 Oct 1;185(7):4354-62. doi: 10.4049/jimmunol.1000313. Epub 2010 Sep 10.

16.

IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.

Peric M, Koglin S, Kim SM, Morizane S, Besch R, Prinz JC, Ruzicka T, Gallo RL, Schauber J.

J Immunol. 2008 Dec 15;181(12):8504-12.

17.

The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.

Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP.

J Immunol. 1997 Mar 15;158(6):2955-63.

PMID:
9058835
18.

Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice.

Kumari S, Bonnet MC, Ulvmar MH, Wolk K, Karagianni N, Witte E, Uthoff-Hachenberg C, Renauld JC, Kollias G, Toftgard R, Sabat R, Pasparakis M, Haase I.

Immunity. 2013 Nov 14;39(5):899-911. doi: 10.1016/j.immuni.2013.10.009. Epub 2013 Nov 7.

19.

The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8 on adipocyte differentiation.

van Asseldonk EJ, Stienstra R, Koenen TB, van Tits LJ, Joosten LA, Tack CJ, Netea MG.

Obesity (Silver Spring). 2010 Nov;18(11):2234-6. doi: 10.1038/oby.2010.55. Epub 2010 Mar 18.

20.

Human β-defensin-3 increases the expression of interleukin-37 through CCR6 in human keratinocytes.

Smithrithee R, Niyonsaba F, Kiatsurayanon C, Ushio H, Ikeda S, Okumura K, Ogawa H.

J Dermatol Sci. 2015 Jan;77(1):46-53. doi: 10.1016/j.jdermsci.2014.12.001. Epub 2014 Dec 10.

PMID:
25541254

Supplemental Content

Support Center